On Saturday, November 4, 2023, Eliksa Therapeutics will be honored with the Partners in Progress Award at the debra of America Annual Benefit at Georgia Aquarium in Atlanta, GA. RSVP here!
Eliksa Therapeutics is a biotech company developing a novel eye drop (ELK-003) to treat corneal abrasions in individuals with Epidermolysis Bullosa (EB). ELK-003 has demonstrated promising safety and efficacy results in a relevant EB animal model and it has the potential to be a transformative therapy for the ocular manifestations associated with EB. Eliksa Therapeutics is fully committed to advancing patient care and to bringing this innovative eye drop to the clinic.
“We are honored to receive this award,” shares Armen Karamanian, MD, PhD, Co-Founder & CEO at Eliksa Therapeutics. “At Eliksa Therapeutics, our dedication to improving the lives of EB patients drives us forward, and ELK-003 represents a major step in our ongoing journey to make a meaningful impact in their ocular treatment and well-being.”
debra of America is proud to partner with this innovative company to improve the quality of life of those impacted by EB.
Tickets to the Annual Benefit are on sale now! Join us for an incredible casino night, complete with your favorite games, cocktails and hors d’oeuvres, an exciting silent auction, and a seated dinner with a view of the aquarium’s sea life. Don’t miss your chance to be a part of this extraordinary event —discover more and RSVP to the debra of America Annual Benefit.